ARCA:PBE

Invesco Biotechnology & Genome ETF

$ 66.78 1.4927 ( +2.29%) 03:59 PM EST
PE Ratio:
40.85
PB Ratio:
3.5
Volume:
8.06K
Dividend Yield %:
0.35
Last Holding update 2025-06-29 30 Stocks (2 new)
Value $221.00 Mil Turnover 12 %
Portfolio Report
Registrant: Invesco Biotechnology & Genome ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Invesco Biotechnology & Genome ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Invesco Biotechnology & Genome ETF Key Statistics

Name Value
Day's Open ($) 65.82
Day's Range ($) 65.54 - 66.86
Day's Volume 8,062
52-Week Range ($) 54.52 - 72.84
Beta 0.82
3-Year Sharpe Ratio 0.05
3-Year Sortino Ratio 0.07
Volatility 14.66
14-Day RSI 51.93
14-Day ATR ($) 1.008101
20-Day SMA ($) 65.19424

Fundamental Data

Name Value
Market Cap (Mil $) 230.391
Shares Outstanding (Mil) 3.45
PE Ratio 40.85
PE Ratio (10y Range) 14.2 - 40.85
PE Ratio (10y Median) 21.74
PB Ratio 3.5
PB Ratio (10y Range) 2.94 - 5.95
PB Ratio (10y Median) 4.15

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.23
Dividend Yield % 0.35
Dividend Yield % (10y Range) 0.01 - 1.84
Dividend Yield % (10y Median) 0.1
Next Dividend Payment Date
Dividend Frequency Quarterly

PBE Invesco Biotechnology & Genome ETF Fundamental Charts

Historical TTM Price-to-Earnings for PBE Invesco Biotechnology & Genome ETF

Historical TTM Price-to-Earnings without NRI for PBE Invesco Biotechnology & Genome ETF

Historical Price-to-Book Ratio for PBE Invesco Biotechnology & Genome ETF

Historical Dividend Yields for PBE Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:PBE

No Available Data

ARCA:PBE is held by these investors

No Available Data
Invesco Biotechnology & Genome... Top Holdings of 2025-04-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
NTRA
Natera Inc
75,925
11,459.4
-2.27%
5.180
-0.12%
0.060
-7.23%
-12.94%
18,818.8
Medical Diagnostics & Research
GILD
Gilead Sciences Inc
106,203
11,314.9
-24.75%
5.110
-1.33%
0.010
+7.51%
+24.68%
141,260.6
Drug Manufacturers
NBIX
Neurocrine Biosciences Inc
102,195
11,005.4
+86.46%
4.970
+2.30%
0.100
+29.49%
-2.08%
13,227.8
Drug Manufacturers
AMGN
Amgen Inc
37,524
10,916.5
-13.62%
4.930
-0.66%
0.010
+12.25%
+20.65%
166,269.5
Drug Manufacturers
TGTX
TG Therapeutics Inc
221,180
10,065.9
+9.88%
4.550
+0.41%
0.140
-4.79%
+24.92%
5,969.2
Biotechnology
UTHR
United Therapeutics Corp
33,135
10,042.9
-4.36%
4.540
-0.21%
0.070
+4.14%
-13.39%
13,785.0
Drug Manufacturers
BIIB
Biogen Inc
82,559
9,996.2
+2.59%
4.520
+0.11%
0.060
+10.84%
-14.35%
19,192.2
Drug Manufacturers
REGN
Regeneron Pharmaceuticals Inc
16,373
9,803.5
-3.92%
4.430
-0.18%
0.020
-2.49%
-19.42%
61,798.4
Biotechnology
ILMN
Illumina Inc
123,695
9,598.7
+39.29%
4.340
+1.22%
0.080
+37.19%
-21.72%
16,559.8
Medical Diagnostics & Research
PTGX
Protagonist Therapeutics Inc
184,113
8,436.1
+20.33%
3.810
+0.64%
0.300
+17.40%
+40.39%
3,358.8
Biotechnology

Invesco Biotechnology & Genome ETF's Historical Top Holdings Breakdowns

Invesco Biotechnology & Genome ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
AXSM
Axsome Therapeutics Inc
2025-04-30
Sold Out
Sold Out
-2.98%
95.65 ($116.78) 137.75
$106.36
-8.92%
Sold Out
0
-71,451
PTCT
PTC Therapeutics Inc
2025-04-30
New Buy
New Buy
+2.89%
39.77 ($50.25) 57.17
$47.08
-6.31%
New holding
128,294
128,294
SRPT
Sarepta Therapeutics Inc
2025-04-30
Sold Out
Sold Out
-2.71%
49.3 ($84.38) 119.02
$13.32
-84.21%
Sold Out
0
-60,764
DVAX
Dynavax Technologies Corp
2025-04-30
New Buy
New Buy
+2.55%
10.31 ($12.81) 14.4
$11.35
-11.40%
New holding
481,349
481,349
INCY
Incyte Corp
2025-04-30
Reduce
Reduce
-2.53%
55.17 ($65.35) 75.26
$70.69
8.17%
Reduce -50.07%
86,742
-86,977
NBIX
Neurocrine Biosciences Inc
2025-04-30
Add
Add
+2.30%
87.54 ($112.46) 152.42
$133.66
18.85%
Add 86.46%
102,195
47,388
GILD
Gilead Sciences Inc
2025-04-30
Reduce
Reduce
-1.33%
95.48 ($107.46) 117.41
$113.56
5.68%
Reduce -24.75%
106,203
-34,937
ILMN
Illumina Inc
2025-04-30
Add
Add
+1.22%
70.3 ($88.29) 132.74
$104.61
18.48%
Add 39.29%
123,695
34,890
XNCR
Xencor Inc
2025-04-30
Add
Add
+0.89%
7.67 ($12.87) 18.28
$9.57
-25.64%
Add 67.09%
446,673
179,350
RPRX
Royalty Pharma PLC
2025-04-30
Reduce
Reduce
-0.89%
30.85 ($32.44) 33.86
$36.01
11.00%
Reduce -27.2%
191,591
-71,592

Invesco Biotechnology & Genome ETF Total Holding History ($B)

To

Invesco Biotechnology & Genome ETF's Asset Allocation

To

Invesco Biotechnology & Genome ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Invesco Biotechnology & Genome ETF's Hypothetical Growth since 2025-04-30

Invesco Biotechnology & Genome ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Invesco Biotechnology & Genome ETF's Holdings Heat Map

Size field:

Invesco Biotechnology & Genome ETF's Holdings Bubble Chart

Invesco Biotechnology & Genome ETF News

  • 1

Discussions on Invesco Biotechnology & Genome ETF

User's Avatar
How would you rate this stock? PBE
No discussions yet.